Surrozen, Inc.
SRZN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001824893
In the last 90 days, Surrozen, Inc. insiders filed 0 open-market purchases and 1 sale; 70 institutions reported holding it in 13F filings for Q2 2026, worth $324.5M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $6.91M in total
- 1
- 13F holdersQ2 2026, +11 vs. previous quarter
- 70
- 13F valueReported value at the end of Q2 2026
- $324.5M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding SRZN, Q2 2026
No superinvestor reported holding SRZN at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Surrozen, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 24, 2026 (view filing)9:00 PM ET | Jul 22 | 2 days | Yu Chen-Ming and 4 others10% Owner | SSale | −325.0K | $21.25 | −$6.91M | −36.1%574.0K after | 2 lots |
| May 5, 2026 (view filing) | May 4 | 1 day | Li YangExec. Vice President, Research | SSale | −1.58K | $33.33 | −$52.8K | −8.4%17.2K after | |
| May 5, 2026 (view filing) | May 4 | 1 day | Williams Charles OChief Operating Officer | SSale | −2.04K | $33.33 | −$67.9K | −10.9%16.6K after | |
| May 5, 2026 (view filing) | May 4 | 1 day | Parker Craig CChief Executive Officer | SSale | −4.52K | $33.33 | −$150.8K | −21.5%16.6K after | |
| Mar 25, 2026 (view filing)8:02 PM ET | Mar 23-24 | 2 days | TCG Crossover GP II, LLC and 3 others10% Owner | PPurchase | +121.9K | $24.72 | +$3.01M | +19.8%736.5K after | 4 lots |
| Mar 16, 2026 (view filing)7:05 PM ET | Mar 12-16 | 4 days | TCG Crossover GP II, LLC and 3 others10% Owner | PPurchase | +49.0K | $24.91 | +$1.22M | +7.8%675.6K after | 6 lots |
| Feb 13, 2026 (view filing)4:19 PM ET | Feb 11-12 | 2 days | TCG Crossover GP II, LLC and 3 others10% Owner | PPurchase | +18.9K | $23.59 | +$444.8K | +3.0%651.1K after | 4 lots |
| Feb 3, 2026 (view filing)8:03 PM ET | Jan 30-Feb 3 | 4 days | TCG Crossover GP II, LLC and 3 others10% Owner | PPurchase | +9.36K | $21.65 | +$202.5K | +1.5%641.7K after | 6 lots |
| Jan 20, 2026 (view filing)7:35 PM ET | Jan 15-20 | 5 days | Svennilson Peter and 6 others10% Owner | PPurchase | +32.5K | $19.74 | +$641.6K | +3.3%1.02M after | 6 lots |
| Jan 20, 2026 (view filing) | Jan 15-20 | 5 days | Kutzkey TimDirector, 10% Owner | PPurchase | +32.5K | $19.74 | +$641.6K | +3.3%1.02M after | 6 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Surrozen, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| The Column Group LLC | 1,916,950 | $49.7M | 56.46% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 1,473,101 | $38.2M | 0.92% | 00.0% | Unchanged |
| Boxer Capital Management, LLC | 1,105,683 | $27.0M | 2.03% | +339,365+44.3% | Added |
| Kalehua Capital Management LLC | 770,356 | $20.0M | 6.38% | 00.0% | Unchanged |
| Millennium Management LLC | 683,079 | $17.7M | 0.01% | −48,059−6.6% | Reduced |
| Point72 Asset Management, L.P. | 664,272 | $17.2M | 0.03% | +664,272 | New |
| VR Adviser, LLC | 632,931 | $16.4M | 0.50% | 00.0% | Unchanged |
| StemPoint Capital LP | 602,798 | $13.8M | 2.39% | −118,822−16.5% | Reduced |
| Perceptive Advisors LLC | 503,985 | $13.1M | 0.20% | +274,592+119.7% | Added |
| Spruce Street Capital LP | 432,040 | $11.2M | 2.20% | 00.0% | Unchanged |